Other Species / Isoforms
  NHERF (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S2-p
______MsADAAAGA
0 18
NHERF (human) ______MsADAAAGA S2-p
NHERF (mouse) ______MsADAAAGE S2-p
NHERF (rat) ______MsADAAAGE S2-p
NHERF (rabbit) ______MSADAAAGA S2
NHERF (dog) ______MSADAAAGA S2
K19-ac
PRLCCLEkGPNGYGF
0 1
NHERF (human) PRLCCLEkGPNGYGF K19-ac
NHERF (mouse) PRLCCLEKGPNGYGF K19
NHERF (rat) PRLCCLEKGPNGYGF K19
NHERF (rabbit) PRLCCLEKGPNGYGF K19
NHERF (dog) PRLCCLEKGPNGYGF K19
K34-ac
HLHGEKGkLGQyIRL
0 4
NHERF (human) HLHGEKGkLGQyIRL K34-ac
NHERF (mouse) HLHGEKGKVGQFIRL K34
NHERF (rat) HLHGEKGKVGQFIRL K34
NHERF (rabbit) HLHGEKGKVGQYIRL K34
NHERF (dog) HLHGEKGKVGQFIRL K34
K34
HLHGEKGKLGQyIRL
0 1
NHERF (human) HLHGEKGKLGQyIRL K34
NHERF (mouse) HLHGEKGkVGQFIRL K34-ub
NHERF (rat) HLHGEKGKVGQFIRL K34
NHERF (rabbit) HLHGEKGKVGQYIRL K34
NHERF (dog) HLHGEKGKVGQFIRL K34
Y38-p
EKGkLGQyIRLVEPG
Upstream
0 9
Treatment
  • Su11274
NHERF (human) EKGkLGQyIRLVEPG Y38-p
NHERF (mouse) EKGkVGQFIRLVEPG F38
NHERF (rat) EKGKVGQFIRLVEPG F38
NHERF (rabbit) EKGKVGQYIRLVEPG Y38
NHERF (dog) EKGKVGQFIRLVEPG F38
S46-p
IRLVEPGsPAEkAGL
1 12
NHERF (human) IRLVEPGsPAEkAGL S46-p
NHERF (mouse) IRLVEPGsPAEkSGL S46-p
NHERF (rat) IRLVEPGSPAEksGL S46
NHERF (rabbit) IRLVEPGSPAEKAGL S46
NHERF (dog) IRLVEPGSPAEKAGL S46
K50-ub
EPGsPAEkAGLLAGD
0 9
NHERF (human) EPGsPAEkAGLLAGD K50-ub
NHERF (mouse) EPGsPAEkSGLLAGD K50-ub
NHERF (rat) EPGSPAEKsGLLAGD K50
NHERF (rabbit) EPGSPAEKAGLLAGD K50
NHERF (dog) EPGSPAEKAGLLAGD K50
K50
EPGsPAEKAGLLAGD
0 1
NHERF (human) EPGsPAEKAGLLAGD K50
NHERF (mouse) EPGsPAEKSGLLAGD K50
NHERF (rat) EPGSPAEksGLLAGD K50-ac
NHERF (rabbit) EPGSPAEKAGLLAGD K50
NHERF (dog) EPGSPAEKAGLLAGD K50
A51
PGsPAEkAGLLAGDr
0 1
NHERF (human) PGsPAEkAGLLAGDr A51
NHERF (mouse) PGsPAEkSGLLAGDR S51
NHERF (rat) PGSPAEksGLLAGDR S51-p
NHERF (rabbit) PGSPAEKAGLLAGDR A51
NHERF (dog) PGSPAEKAGLLAGDR A51
R58-m1
AGLLAGDrLVEVNGE
0 1
NHERF (human) AGLLAGDrLVEVNGE R58-m1
NHERF (mouse) SGLLAGDRLVEVNGE R58
NHERF (rat) sGLLAGDRLVEVNGE R58
NHERF (rabbit) AGLLAGDRLVEVNGE R58
NHERF (dog) AGLLAGDRLVEVNGE R58
K69-ub
VNGENVEkETHQQVV
0 2
NHERF (human) VNGENVEkETHQQVV K69-ub
NHERF (mouse) VNGENVEkETHQQVV K69-ub
NHERF (rat) VNGENVEKETHQQVV K69
NHERF (rabbit) VNGENVEKETHQQVV K69
NHERF (dog) VNGENVEKETHQQVV K69
K69
VNGENVEKETHQQVV
0 1
NHERF (human) VNGENVEKETHQQVV K69
NHERF (mouse) VNGENVEKETHQQVV K69
NHERF (rat) VNGENVEkETHQQVV K69-ac
NHERF (rabbit) VNGENVEKETHQQVV K69
NHERF (dog) VNGENVEKETHQQVV K69
S77-p
ETHQQVVsRIRAALN
Upstream
Downstream
4 0
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
Kinase, in vitro:
  • PKCA (human)
Treatment
  • calyculin_A
NHERF (human) ETHQQVVsRIRAALN S77-p
NHERF (mouse) ETHQQVVsRIRAALN S77-p
NHERF (rat) ETHQQVVSRIRAALN S77
NHERF (rabbit) ETHQQVVSRIRAALN S77
NHERF (dog) ETHQQVVSRIRAALN S77
T95-p
LLVVDPEtDEQLQkL
Upstream
Downstream
2 0
Effects on Modified Protein
  • phosphorylation
Treatment
  • calyculin_A
  • dopamine
  • PTH
view more >
NHERF (human) LLVVDPEtDEQLQkL T95-p
NHERF (mouse) LLVVDPETDERLKkL T95
NHERF (rat) LLVVDPETDEQLkKL T95
NHERF (rabbit) LLVVDPDTDEQFRKL T95
NHERF (dog) LLVVDPDADERLQKL A95
Q100
PEtDEQLQkLGVQVR
0 1
NHERF (human) PEtDEQLQkLGVQVR Q100
NHERF (mouse) PETDERLKkLGVSIR K100
NHERF (rat) PETDEQLkKLGVPIR K100-ac
NHERF (rabbit) PDTDEQFRKLGVQIR R100
NHERF (dog) PDADERLQKLGVPVR Q100
K101-ub
EtDEQLQkLGVQVRE
0 13
NHERF (human) EtDEQLQkLGVQVRE K101-ub
NHERF (mouse) ETDERLKkLGVSIRE K101-ub
NHERF (rat) ETDEQLkKLGVPIRE K101
NHERF (rabbit) DTDEQFRKLGVQIRG K101
NHERF (dog) DADERLQKLGVPVRE K101
A116
ELLRAQEAPGQAEPP
0 2
NHERF (human) ELLRAQEAPGQAEPP A116
NHERF (mouse) ELLRPQEksEQAEPP K116-ub
NHERF (rat) ELLRAQEkSEHTEPP K116-ub
NHERF (rabbit) ELLRAQAGPEQAGPP G116
NHERF (dog) ELLRAQDGPGQAEPP G116
P117
LLRAQEAPGQAEPPA
0 3
NHERF (human) LLRAQEAPGQAEPPA P117
NHERF (mouse) LLRPQEksEQAEPPA S117-p
NHERF (rat) LLRAQEkSEHTEPPA S117
NHERF (rabbit) LLRAQAGPEQAGPPA P117
NHERF (dog) LLRAQDGPGQAEPPA P117
K142
NEPREADKSHPEQRE
0 1
NHERF (human) NEPREADKSHPEQRE K142
NHERF (mouse) GDQNEAEkSHLRELR K139-ub
NHERF (rat) GDQNEAEKSHLERCE K139
NHERF (rabbit) NEPREVEKSHPERRE K142
NHERF (dog) PEPREAERSGPERRE R149
K142
NEPREADKSHPEQRE
0 1
NHERF (human) NEPREADKSHPEQRE K142
NHERF (mouse) GDQNEAEKSHLRELR K139
NHERF (rat) GDQNEAEkSHLERCE K139-ac
NHERF (rabbit) NEPREVEKSHPERRE K142
NHERF (dog) PEPREAERSGPERRE R149
T156-p
ELRPRLCtMKKGPsG
Upstream
Downstream
2 2
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
Effects on Biological Processes:
  • cell growth, induced
Kinase, in vitro:
  • Akt1 (human)
  • p90RSK (human)
Putative in vivo kinases:
  • Akt1 (human)
  • p90RSK (human)
Treatment
  • Akt-I-1
  • serum
NHERF (human) ELRPRLCtMKKGPsG T156-p
NHERF (mouse) ELRPRLCTMKKGPNG T151
NHERF (rat) ELRPRLCTMKKGPNG T153
NHERF (rabbit) ELRPRLCAMKKGPNG A156
NHERF (dog) ELRPRLCAMKKGANG A163
S162-p
CtMKKGPsGyGFNLH
Upstream
Downstream
3 11
Effects on Modified Protein
  • molecular association, regulation
Kinase, in vitro:
  • PKCA (human)
NHERF (human) CtMKKGPsGyGFNLH S162-p
NHERF (mouse) CTMKKGPNGYGFNLH N157
NHERF (rat) CTMKKGPNGYGFNLH N159
NHERF (rabbit) CAMKKGPNGYGFNLH N162
NHERF (dog) CAMKKGANGYGFNLH N169
Y164-p
MKKGPsGyGFNLHsD
0 2
NHERF (human) MKKGPsGyGFNLHsD Y164-p
NHERF (mouse) MKKGPNGYGFNLHSD Y159
NHERF (rat) MKKGPNGYGFNLHsD Y161
NHERF (rabbit) MKKGPNGYGFNLHSD Y164
NHERF (dog) MKKGANGYGFNLHSD Y171
S170-p
GyGFNLHsDksKPGQ
0 2
NHERF (human) GyGFNLHsDksKPGQ S170-p
NHERF (mouse) GYGFNLHSDKSkPGQ S165
NHERF (rat) GYGFNLHsDKSKPGQ S167-p
NHERF (rabbit) GYGFNLHSDKSRPGQ S170
NHERF (dog) GYGFNLHSDKSKPGQ S177
K172-ub
GFNLHsDksKPGQFI
0 1
NHERF (human) GFNLHsDksKPGQFI K172-ub
NHERF (mouse) GFNLHSDKSkPGQFI K167
NHERF (rat) GFNLHsDKSKPGQFI K169
NHERF (rabbit) GFNLHSDKSRPGQFI K172
NHERF (dog) GFNLHSDKSKPGQFI K179
S173-p
FNLHsDksKPGQFIR
0 2
NHERF (human) FNLHsDksKPGQFIR S173-p
NHERF (mouse) FNLHSDKSkPGQFIR S168
NHERF (rat) FNLHsDKSKPGQFIR S170
NHERF (rabbit) FNLHSDKSRPGQFIR S173
NHERF (dog) FNLHSDKSKPGQFIR S180
K174
NLHsDksKPGQFIRs
0 1
NHERF (human) NLHsDksKPGQFIRs K174
NHERF (mouse) NLHSDKSkPGQFIRA K169-ub
NHERF (rat) NLHsDKSKPGQFIRA K171
NHERF (rabbit) NLHSDKSRPGQFIRA R174
NHERF (dog) NLHSDKSKPGQFIRA K181
S181-p
KPGQFIRsVDPDsPA
1 2
NHERF (human) KPGQFIRsVDPDsPA S181-p
NHERF (mouse) kPGQFIRAVDPDsPA A176
NHERF (rat) KPGQFIRAVDPDSPA A178
NHERF (rabbit) RPGQFIRAVDPDSPA A181
NHERF (dog) KPGQFIRAVDPDSPA A188
S186-p
IRsVDPDsPAEAsGL
0 3
NHERF (human) IRsVDPDsPAEAsGL S186-p
NHERF (mouse) IRAVDPDsPAEASGL S181-p
NHERF (rat) IRAVDPDSPAEASGL S183
NHERF (rabbit) IRAVDPDSPAEASGL S186
NHERF (dog) IRAVDPDSPAEASGL S193
S191-p
PDsPAEAsGLRAQDR
0 1
NHERF (human) PDsPAEAsGLRAQDR S191-p
NHERF (mouse) PDsPAEASGLRAQDR S186
NHERF (rat) PDSPAEASGLRAQDR S188
NHERF (rabbit) PDSPAEASGLREQDR S191
NHERF (dog) PDSPAEASGLRAQDR S198
S217-p
KQHGDVVsAIRAGGD
0 3
NHERF (human) KQHGDVVsAIRAGGD S217-p
NHERF (mouse) KQHGDVVSAIkGGGD S212
NHERF (rat) KQHGDVVSAIkAGGD S214
NHERF (rabbit) KQHGDVVTAIKAGGD T217
NHERF (dog) KQHGDVVSAIKAGGD S225
R220
GDVVsAIRAGGDETk
0 1
NHERF (human) GDVVsAIRAGGDETk R220
NHERF (mouse) GDVVSAIkGGGDEAK K215-ub
NHERF (rat) GDVVSAIKAGGDEAK K217
NHERF (rabbit) GDVVTAIKAGGDEAK K220
NHERF (dog) GDVVSAIKAGGDETK K228
R220
GDVVsAIRAGGDETk
0 1
NHERF (human) GDVVsAIRAGGDETk R220
NHERF (mouse) GDVVSAIKGGGDEAK K215
NHERF (rat) GDVVSAIkAGGDEAK K217-ac
NHERF (rabbit) GDVVTAIKAGGDEAK K220
NHERF (dog) GDVVSAIKAGGDETK K228
K227-ub
RAGGDETkLLVVDRE
0 1
NHERF (human) RAGGDETkLLVVDRE K227-ub
NHERF (mouse) kGGGDEAKLLVVDkE K222
NHERF (rat) kAGGDEAKLLVVDkE K224
NHERF (rabbit) KAGGDEAKLLVVDKE K227
NHERF (dog) KAGGDETKLLVVDKE K235
R233
TkLLVVDRETDEFFk
0 1
NHERF (human) TkLLVVDRETDEFFk R233
NHERF (mouse) AKLLVVDkETDEFFk K228-ub
NHERF (rat) AKLLVVDKETDEFFK K230
NHERF (rabbit) AKLLVVDKETDEFFK K233
NHERF (dog) TKLLVVDKETDEFFK K241
R233
TkLLVVDRETDEFFk
0 2
NHERF (human) TkLLVVDRETDEFFk R233
NHERF (mouse) AKLLVVDkETDEFFk K228-ac
NHERF (rat) AKLLVVDkETDEFFK K230-ac
NHERF (rabbit) AKLLVVDKETDEFFK K233
NHERF (dog) TKLLVVDKETDEFFK K241
K240-ac
RETDEFFkKCRVIPs
0 2
NHERF (human) RETDEFFkKCRVIPs K240-ac
NHERF (mouse) kETDEFFkKCKVIPS K235-ac
NHERF (rat) kETDEFFKKCRVTPS K237
NHERF (rabbit) KETDEFFKKCKVVPS K240
NHERF (dog) KETDEFFKKCKVIPS K248
S247-p
kKCRVIPsQEHLNGP
0 2
NHERF (human) kKCRVIPsQEHLNGP S247-p
NHERF (mouse) kKCKVIPSQEHLDGP S242
NHERF (rat) KKCRVTPSQEHLDGP S244
NHERF (rabbit) KKCKVVPSSEHLNGP S247
NHERF (dog) KKCKVIPSQEHLTGP S255
T260-p
GPLPVPFtNGEIQKE
0 1
NHERF (human) GPLPVPFtNGEIQKE T260-p
NHERF (mouse) GPLPEPFSNGEIQkE S255
NHERF (rat) GPLPEPFSNGEIQKE S257
NHERF (rabbit) GPLPEPFTNGEIQKN T260
NHERF (dog) GPLPEPFTNGEIRKE T268
K266
FtNGEIQKENsREAL
0 1
NHERF (human) FtNGEIQKENsREAL K266
NHERF (mouse) FSNGEIQkEssREAL K261-ub
NHERF (rat) FSNGEIQKENsREAL K263
NHERF (rabbit) FTNGEIQKNNPETLA K266
NHERF (dog) FTNGEIRKENSREPL K274
N268
NGEIQKENsREALAE
0 1
NHERF (human) NGEIQKENsREALAE N268
NHERF (mouse) NGEIQkEssREALVE S263-p
NHERF (rat) NGEIQKENsREALVE N265
NHERF (rabbit) TNGEIQKNNPETLAP N267
NHERF (dog) NGEIRKENSREPLAE N276
S269-p
GEIQKENsREALAEA
Upstream
1 28
Treatment
  • angiotensin_2
  • dasatinib
  • EGF
  • LRRK2-IN-1
  • metformin
  • PTH(1-34)
view more >
NHERF (human) GEIQKENsREALAEA S269-p
NHERF (mouse) GEIQkEssREALVEP S264-p
NHERF (rat) GEIQKENsREALVEP S266-p
NHERF (rabbit) NGEIQKNNPETLAPA N268
NHERF (dog) GEIRKENSREPLAEV S277
L278
EALAEAALEsPRPAL
0 15
NHERF (human) EALAEAALEsPRPAL L278
NHERF (mouse) EALVEPAsEsPRPAL S273-p
NHERF (rat) EALVEPAsEsPRPAL S275-p
NHERF (rabbit) ETLAPAASESPRPAL S277
NHERF (dog) EPLAEVASESPRSAL S286
S280-p
LAEAALEsPRPALVR
Upstream
Downstream
4 205
Effects on Modified Protein
  • molecular association, regulation
  • protein conformation
Effects on Biological Processes:
  • apoptosis, induced
  • cell adhesion, inhibited
  • cell cycle regulation
  • cell growth, inhibited
  • cytoskeletal reorganization
Putative in vivo kinases:
  • CDK1 (human)
Treatment
  • angiotensin_2
  • EGF
  • ischemia
  • LRRK2-IN-1
  • metformin
  • nocodazole
view more >
NHERF (human) LAEAALEsPRPALVR S280-p
NHERF (mouse) LVEPAsEsPRPALAR S275-p
NHERF (rat) LVEPAsEsPRPALAR S277-p
NHERF (rabbit) LAPAASESPRPALAR S279
NHERF (dog) LAEVASESPRSALAR S288
S288-p
PRPALVRsAssDtsE
Upstream
1 86
Regulatory protein:
  • PRP4 (human)
Treatment
  • nocodazole
NHERF (human) PRPALVRsAssDtsE S288-p
NHERF (mouse) PRPALARsAssDtsE S283-p
NHERF (rat) PRPALARsAssDtsE S285-p
NHERF (rabbit) PRPALARsAssDTSE S287-p
NHERF (dog) PRSALARSTSSDTSE S296
S290-p
PALVRsAssDtsEEL
Upstream
Downstream
5 151
Effects on Modified Protein
  • molecular association, regulation
  • protein conformation
Phosphatases, in vitro:
  • PPP1CA (human)
Putative in vivo kinases:
  • GRK6 (human)
Putative upstream phosphatases:
  • PPP1CA (human)
Treatment
  • metformin
  • PTH(1-34)
  • tautomycetin
view more >
NHERF (human) PALVRsAssDtsEEL S290-p
NHERF (mouse) PALARsAssDtsEEL S285-p
NHERF (rat) PALARsAssDtsEEL S287-p
NHERF (rabbit) PALARsAssDTSEEL S289-p
NHERF (dog) SALARSTSSDTSEEL S298
S291-p
ALVRsAssDtsEELN
Upstream
2 66
Treatment
  • metformin
  • PTH(1-34)
NHERF (human) ALVRsAssDtsEELN S291-p
NHERF (mouse) ALARsAssDtsEELN S286-p
NHERF (rat) ALARsAssDtsEELN S288-p
NHERF (rabbit) ALARsAssDTSEELA S290-p
NHERF (dog) ALARSTSSDTSEELN S299
T293-p
VRsAssDtsEELNsQ
Upstream
1 54
Treatment
  • EGF
  • PTH(1-34)
  • U0126
view more >
NHERF (human) VRsAssDtsEELNsQ T293-p
NHERF (mouse) ARsAssDtsEELNsQ T288-p
NHERF (rat) ARsAssDtsEELNAQ T290-p
NHERF (rabbit) ARsAssDTSEELASQ T292
NHERF (dog) ARSTSSDTSEELNSQ T301
S294-p
RsAssDtsEELNsQD
0 36
NHERF (human) RsAssDtsEELNsQD S294-p
NHERF (mouse) RsAssDtsEELNsQD S289-p
NHERF (rat) RsAssDtsEELNAQD S291-p
NHERF (rabbit) RsAssDTSEELASQD S293
NHERF (dog) RSTSSDTSEELNSQD S302
S299-p
DtsEELNsQDsPPKQ
1 20
NHERF (human) DtsEELNsQDsPPKQ S299-p
NHERF (mouse) DtsEELNsQDsPKRQ S294-p
NHERF (rat) DtsEELNAQDsPKRH A296
NHERF (rabbit) DTSEELASQDSPKKE S298
NHERF (dog) DTSEELNSQDSPRKQ S307
S302-p
EELNsQDsPPKQDST
Upstream
Downstream
4 81
Effects on Modified Protein
  • molecular association, regulation
  • protein conformation
Effects on Biological Processes:
  • apoptosis, induced
  • cell adhesion, inhibited
  • cell cycle regulation
  • cell growth, inhibited
  • cytoskeletal reorganization
Putative in vivo kinases:
  • CDK1 (human)
Treatment
  • metformin
  • PTH(1-34)
NHERF (human) EELNsQDsPPKQDST S302-p
NHERF (mouse) EELNsQDsPKRQVst S297-p
NHERF (rat) EELNAQDsPKRHDST S299-p
NHERF (rabbit) EELASQDSPKKEDST S301
NHERF (dog) EELNSQDSPRKQDST S310
S308
DsPPKQDSTAPSsTS
0 4
NHERF (human) DsPPKQDSTAPSsTS S308
NHERF (mouse) DsPKRQVstEPSSTS S303-p
NHERF (rat) DsPKRHDSTEPSSTS S305
NHERF (rabbit) DSPKKEDSTAPSSTS S307
NHERF (dog) DSPRKQDSTAPSSTS S316
T309
sPPKQDSTAPSsTSS
0 3
NHERF (human) sPPKQDSTAPSsTSS T309
NHERF (mouse) sPKRQVstEPSSTSS T304-p
NHERF (rat) sPKRHDSTEPSSTSS T306
NHERF (rabbit) SPKKEDSTAPSSTSS T308
NHERF (dog) SPRKQDSTAPSSTSS T317
S313-p
QDSTAPSsTSSsDPI
0 2
NHERF (human) QDSTAPSsTSSsDPI S313-p
NHERF (mouse) QVstEPSSTSSSSSD S308
NHERF (rat) HDSTEPSSTSSSSDP S310
NHERF (rabbit) EDSTAPSSTSSSSDP S312
NHERF (dog) QDSTAPSSTSSSSDP S321
S317-p
APSsTSSsDPILDFN
0 1
NHERF (human) APSsTSSsDPILDFN S317-p
NHERF (mouse) EPSSTSSSSSDPILD S312
NHERF (rat) EPSSTSSSSDPILDF S314
NHERF (rabbit) APSSTSSSSDPILDF S316
NHERF (dog) APSSTSSSSDPILDF S325
S326-p
PILDFNIsLAMAKER
0 1
NHERF (human) PILDFNIsLAMAKER S326-p
NHERF (mouse) PILDLNISLAVAKER S323
NHERF (rat) PILDFNISLAVAKER S324
NHERF (rabbit) PILDFSISLAVAKER S326
NHERF (dog) PILDFNISLAMARER S335
S339-p
ERAHQKRssKRAPQM
Upstream
Downstream
5 19
Effects on Modified Protein
  • molecular association, regulation
Kinase, in vitro:
  • PKCA (human)
Putative in vivo kinases:
  • PKCA (human)
Treatment
  • phorbol_ester
NHERF (human) ERAHQKRssKRAPQM S339-p
NHERF (mouse) ERAHQKRSSKRAPQM S336
NHERF (rat) ERAHQKRssKRAPQM S337-p
NHERF (rabbit) ERAHQKRSSRRAPQM S339
NHERF (dog) ERAHQKRssKRAPQM S348-p
S340-p
RAHQKRssKRAPQMD
Upstream
Downstream
5 13
Effects on Modified Protein
  • molecular association, regulation
Kinase, in vitro:
  • PKCA (human)
Putative in vivo kinases:
  • PKCA (human)
Treatment
  • phorbol_ester
NHERF (human) RAHQKRssKRAPQMD S340-p
NHERF (mouse) RAHQKRSSKRAPQMD S337
NHERF (rat) RAHQKRssKRAPQMD S338-p
NHERF (rabbit) RAHQKRSSRRAPQMD S340
NHERF (dog) RAHQKRssKRAPQMD S349-p
S349-p
RAPQMDWskkNELFS
0 1
NHERF (human) RAPQMDWskkNELFS S349-p
NHERF (mouse) RAPQMDWSKKNELFS S346
NHERF (rat) RAPQMDWSKKNELFS S347
NHERF (rabbit) RAPQMDWSEKKELFS S349
NHERF (dog) RAPQMDWSKKNELFS S358
K350-ub
APQMDWskkNELFSN
0 1
NHERF (human) APQMDWskkNELFSN K350-ub
NHERF (mouse) APQMDWSKKNELFSN K347
NHERF (rat) APQMDWSKKNELFSN K348
NHERF (rabbit) APQMDWSEKKELFSN E350
NHERF (dog) APQMDWSKKNELFSN K359
K351-ub
PQMDWskkNELFSNL
0 1
NHERF (human) PQMDWskkNELFSNL K351-ub
NHERF (mouse) PQMDWSKKNELFSNL K348
NHERF (rat) PQMDWSKKNELFSNL K349
NHERF (rabbit) PQMDWSEKKELFSNL K351
NHERF (dog) PQMDWSKKNELFSNL K360